• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物人工主动脉瓣置换术后血流动力学结构性瓣膜退变的当前定义缺乏一致性。

Current definitions of hemodynamic structural valve deterioration after bioprosthetic aortic valve replacement lack consistency.

作者信息

Velders Bart J J, Vriesendorp Michiel D, Asch Federico M, Reardon Michael J, Dagenais Francois, Moront Michael G, Sabik Iii Joseph F, Groenwold Rolf H H, Klautz Robert J M

机构信息

Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, The Netherlands.

Department of Cardiovascular Core Laboratories, MedStar Health Research Institute, and Georgetown University, Washington, DC.

出版信息

JTCVS Open. 2024 Mar 19;19:68-90. doi: 10.1016/j.xjon.2024.02.023. eCollection 2024 Jun.

DOI:10.1016/j.xjon.2024.02.023
PMID:39015469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11247222/
Abstract

OBJECTIVE

New echocardiographic definitions have been proposed for hemodynamic structural valve deterioration. We aimed to study their consistency in classifying structural valve deterioration after surgical aortic valve replacement.

METHODS

Data were used of patients undergoing surgical aortic valve replacement in a multicenter, prospective cohort study with a 5-year follow-up. All patients received the same stented bioprosthesis. Echocardiographic parameters were assessed by an independent core laboratory. Moderate or greater stenotic hemodynamic structural valve deterioration was defined according to Capodanno and colleagues, Dvir and colleagues, and the Valve Academic Research Consortium 3; regurgitation data were not considered in this analysis. Consistency was quantified on the basis of structural valve deterioration classification at subsequent time points.

RESULTS

A total of 1118 patients received implants. Patients' mean age was 70 years, and 75% were male. Hemodynamic structural valve deterioration at any visit was present in 51 patients (4.6%), 32 patients (2.9%), and 34 patients (3.0%) according to Capodanno, Dvir, and Valve Academic Research Consortium 3. A total of 1064 patients (95%) were never labeled with structural valve deterioration by any definition. After the first classification with structural valve deterioration, 59%, 59%, and 65% had no subsequent structural valve deterioration classification according to Capodanno, Dvir, and Valve Academic Research Consortium 3, respectively.

CONCLUSIONS

The current definitions of hemodynamic structural valve deterioration are strong negative predictors but inconsistent positive discriminators for the detection of stenotic hemodynamic structural valve deterioration. Although the diagnosis of structural valve deterioration may be categorical, echocardiographic indices lack this degree of precision in the first 5 years after surgical aortic valve replacement. The inconsistency of current structural valve deterioration definitions impedes the detection of true valve degeneration, which challenges the clinical usefulness of these definitions.

摘要

目的

已提出用于血流动力学结构性瓣膜退变的新超声心动图定义。我们旨在研究这些定义在外科主动脉瓣置换术后结构性瓣膜退变分类中的一致性。

方法

数据来自一项多中心前瞻性队列研究中接受外科主动脉瓣置换术且随访5年的患者。所有患者均接受相同的带支架生物瓣膜。超声心动图参数由独立的核心实验室评估。根据卡波丹诺及其同事、德维尔及其同事以及瓣膜学术研究联盟3的标准,定义为中度或更严重的狭窄性血流动力学结构性瓣膜退变;本分析未考虑反流数据。基于后续时间点的结构性瓣膜退变分类对一致性进行量化。

结果

共有1118例患者接受了植入手术。患者的平均年龄为70岁,75%为男性。根据卡波丹诺、德维尔和瓣膜学术研究联盟3的标准,在任何一次随访中出现血流动力学结构性瓣膜退变的患者分别有51例(4.6%)、32例(2.9%)和34例(3.0%)。共有1064例患者(95%)无论依据何种定义均未被标记为结构性瓣膜退变。在首次被分类为结构性瓣膜退变后,根据卡波丹诺、德维尔和瓣膜学术研究联盟3的标准,分别有59%、59%和65%的患者在后续未被再次分类为结构性瓣膜退变。

结论

目前血流动力学结构性瓣膜退变的定义对于检测狭窄性血流动力学结构性瓣膜退变是强有力的阴性预测指标,但作为阳性判别指标时并不一致。尽管结构性瓣膜退变的诊断可能是明确的,但在外科主动脉瓣置换术后的前5年,超声心动图指标缺乏这种精确程度。当前结构性瓣膜退变定义的不一致性阻碍了对真正瓣膜退变的检测,这对这些定义的临床实用性提出了挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/abd06e31d849/fx10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/19719bfdaf03/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/3321bdc8ad21/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/84d05fae9d18/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/3b0eb60d9ea4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/65189b547640/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/a6b065be0f09/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/2099537f7967/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/e5a68fd93210/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/fea98be5db0c/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/c339455a3b81/fx3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/299c0323cf72/fx4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/6c4b7a37557a/fx5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/34683e90469b/fx6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/06572e38f1d6/fx7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/196a10210709/fx8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/8ce06eb85b88/fx9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/abd06e31d849/fx10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/19719bfdaf03/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/3321bdc8ad21/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/84d05fae9d18/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/3b0eb60d9ea4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/65189b547640/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/a6b065be0f09/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/2099537f7967/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/e5a68fd93210/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/fea98be5db0c/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/c339455a3b81/fx3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/299c0323cf72/fx4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/6c4b7a37557a/fx5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/34683e90469b/fx6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/06572e38f1d6/fx7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/196a10210709/fx8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/8ce06eb85b88/fx9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac6/11247222/abd06e31d849/fx10.jpg

相似文献

1
Current definitions of hemodynamic structural valve deterioration after bioprosthetic aortic valve replacement lack consistency.生物人工主动脉瓣置换术后血流动力学结构性瓣膜退变的当前定义缺乏一致性。
JTCVS Open. 2024 Mar 19;19:68-90. doi: 10.1016/j.xjon.2024.02.023. eCollection 2024 Jun.
2
Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves.外科植入生物瓣主动脉瓣的血液动力学恶化。
J Am Coll Cardiol. 2018 Jul 17;72(3):241-251. doi: 10.1016/j.jacc.2018.04.064. Epub 2018 Jul 9.
3
The 10-year horizon: Survival and structural valve degeneration in first-generation transcatheter aortic valves.10 年展望:第一代经导管主动脉瓣中生存和结构性瓣膜退化。
Arch Cardiovasc Dis. 2022 Jun-Jul;115(6-7):369-376. doi: 10.1016/j.acvd.2022.04.007. Epub 2022 May 26.
4
Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement.生物瓣外科主动脉瓣置换术后血流动力学瓣膜恶化的发生率、时间、相关性和结局。
Circulation. 2018 Sep 4;138(10):971-985. doi: 10.1161/CIRCULATIONAHA.118.035150.
5
Circulating Progenitor Cells Are Associated With Bioprosthetic Aortic Valve Deterioration: A Preliminary Study.循环祖细胞与生物瓣主动脉瓣恶化相关:一项初步研究。
J Am Heart Assoc. 2023 Jan 17;12(2):e027364. doi: 10.1161/JAHA.122.027364. Epub 2023 Jan 16.
6
Durability of a bovine pericardial aortic bioprosthesis based on Valve Academic Research Consortium-3 echocardiographic criteria.基于瓣膜学术研究联盟-3超声心动图标准的牛心包主动脉生物假体的耐久性
JTCVS Open. 2022 May 29;11:72-80. doi: 10.1016/j.xjon.2022.05.008. eCollection 2022 Sep.
7
Determinants of Bioprosthetic Aortic Valve Degeneration.生物瓣主动脉瓣退行性变的决定因素。
JACC Cardiovasc Imaging. 2020 Feb;13(2 Pt 1):345-353. doi: 10.1016/j.jcmg.2019.01.027. Epub 2019 Mar 13.
8
Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review.经主动脉瓣或二尖瓣置换术后生物瓣功能障碍的标准化定义:JACC 现状述评。
J Am Coll Cardiol. 2022 Aug 2;80(5):545-561. doi: 10.1016/j.jacc.2022.06.002.
9
Hemodynamic Outcome and Valve Durability Beyond Five Years After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后五年以上的血液动力学结果和瓣膜耐久性。
J Invasive Cardiol. 2020 Mar;32(3):82-87. doi: 10.25270/jic/19.00346.
10
Long-term results of a stented bioprosthetic valve in the aortic position: structural valve deterioration and valve haemodynamic deterioration of bovine pericardial and porcine valves.主动脉位带支架生物瓣膜的长期结果:牛心包瓣和猪瓣膜的结构性瓣膜退变及瓣膜血流动力学恶化
Eur J Cardiothorac Surg. 2023 Feb 3;63(2). doi: 10.1093/ejcts/ezac506.

引用本文的文献

1
Bioprosthetic Aortic Valve Degeneration After TAVR and SAVR: Incidence, Diagnosis, Predictors, and Management.经导管主动脉瓣置换术和外科主动脉瓣置换术后生物人工主动脉瓣退变:发生率、诊断、预测因素及管理
J Cardiovasc Dev Dis. 2024 Nov 30;11(12):384. doi: 10.3390/jcdd11120384.
2
Seven-year outcomes after surgical aortic valve replacement with a stented bovine pericardial bioprosthesis in over 1100 patients: a prospective multicentre analysis.1100 多名患者接受带支架牛心包生物瓣膜置换主动脉瓣术后七年的随访结果:一项前瞻性多中心分析。
Eur J Cardiothorac Surg. 2024 Dec 26;67(1). doi: 10.1093/ejcts/ezae414.

本文引用的文献

1
Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk.经皮自膨式或外科主动脉瓣置换术治疗中高危患者的结构性瓣膜衰败。
JAMA Cardiol. 2023 Feb 1;8(2):111-119. doi: 10.1001/jamacardio.2022.4627.
2
Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review.经主动脉瓣或二尖瓣置换术后生物瓣功能障碍的标准化定义:JACC 现状述评。
J Am Coll Cardiol. 2022 Aug 2;80(5):545-561. doi: 10.1016/j.jacc.2022.06.002.
3
Surgical aortic valve replacement with a stented pericardial bioprosthesis: 5-year outcomes.
带支架心包生物瓣的主动脉瓣置换术:5 年结果。
Eur J Cardiothorac Surg. 2022 Aug 3;62(3). doi: 10.1093/ejcts/ezac374.
4
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research.瓣膜学术研究联合会 3:主动脉瓣临床研究更新终点定义。
J Am Coll Cardiol. 2021 Jun 1;77(21):2717-2746. doi: 10.1016/j.jacc.2021.02.038. Epub 2021 Apr 19.
5
Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy.经导管和外科生物瓣叶亚临床血栓形成:PARTNER 3 心脏计算机断层扫描子研究。
J Am Coll Cardiol. 2020 Jun 23;75(24):3003-3015. doi: 10.1016/j.jacc.2020.04.043.
6
Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study.Evolut 低危亚组研究中的生物瓣主动脉瓣叶增厚。
J Am Coll Cardiol. 2020 May 19;75(19):2430-2442. doi: 10.1016/j.jacc.2020.03.022. Epub 2020 Mar 28.
7
One-year outcomes associated with a novel stented bovine pericardial aortic bioprosthesis.新型带支架牛心包主动脉生物瓣的一年随访结果。
J Thorac Cardiovasc Surg. 2018 Oct;156(4):1368-1377.e5. doi: 10.1016/j.jtcvs.2018.03.171. Epub 2018 Apr 18.
8
Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves.经导管主动脉瓣生物瓣和外科生物瓣结构性瓣叶衰败的标准化定义。
Circulation. 2018 Jan 23;137(4):388-399. doi: 10.1161/CIRCULATIONAHA.117.030729.
9
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).评估经导管和外科主动脉生物瓣膜长期耐久性时结构恶化和瓣膜功能衰竭的标准化定义:欧洲经皮心血管介入协会(EAPCI)的共识声明,得到欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)认可
Eur Heart J. 2017 Dec 1;38(45):3382-3390. doi: 10.1093/eurheartj/ehx303.
10
Safety, effectiveness and haemodynamic performance of a new stented aortic valve bioprosthesis.一种新型带支架主动脉瓣生物假体的安全性、有效性和血液动力学性能。
Eur J Cardiothorac Surg. 2017 Sep 1;52(3):425-431. doi: 10.1093/ejcts/ezx066.